Global Pharmaceuticals & Biotech Top Stock Picks from Analysts

Cabaletta Bio

Market Cap: US$140.9m

A clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with autoimmune diseases.

Japan Tissue Engineering

Market Cap: JP¥20.4b

Engages in the regenerative medicine business in Japan.

Agenus

Market Cap: US$136.7m

A clinical-stage biotechnology company, discovers and develops therapies to activate the body's immune system against cancer and infections in the United States and internationally.

Molecular Partners

Market Cap: CHF 108.4m

A clinical-stage biotechnology company, designs and develops designed ankyrin repeat proteins therapeutics for the treatment of oncology diseases in Switzerland.

Zura Bio

Market Cap: US$134.6m

A clinical-stage biotechnology company, develops medicines for immune and inflammatory disorders in the United States.

Avalo Therapeutics

Market Cap: US$133.6m

A clinical stage biotechnology company, focuses on the development of therapies for the treatment of immune dysregulation in the Unites States.

vTv Therapeutics

Market Cap: US$132.8m

A clinical stage biopharmaceutical company, focuses on the development of orally administered treatments for metabolic and inflammatory diseases.

Compugen

Market Cap: US$131.9m

A clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutics and product candidates in Israel, the United States, and Europe.

StemRIM

Market Cap: JP¥19.4b

A biotechnology company, develops regeneration medicines for the treatment of intractable diseases.

Anika Therapeutics

Market Cap: US$131.1m

A joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and arthrosurface joint solutions in the United States, Europe, and internationally.

Genelux

Market Cap: US$129.9m

A clinical-stage biopharmaceutical company, focuses on developing oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types.

AVITA Medical

Market Cap: US$128.9m

Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.

Zentalis Pharmaceuticals

Market Cap: US$127.7m

A clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers in the United States.

Inhibikase Therapeutics

Market Cap: US$127.4m

Operates as a clinical-stage pharmaceutical company that develops therapeutics for Parkinson’s disease and related disorders.

Protalix BioTherapeutics

Market Cap: US$126.8m

A biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system.

TuHURA Biosciences

Market Cap: US$126.6m

A clinical stage immuno-oncology company, that develops novel technologies for the treatment of cancer immunotherapies.

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E)

Market Cap: ج.م6.1b

Produces and sells a range of branded generic pharmaceuticals, food supplements, veterinary products, and nutraceuticals in Egypt.

Corbus Pharmaceuticals Holdings

Market Cap: US$122.8m

A biopharmaceutical company, develops products to defeat serious illness.

MacroGenics

Market Cap: US$122.6m

A clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics to treat cancer in the United States.

Scancell Holdings

Market Cap: UK£90.8m

A clinical stage biopharmaceutical company, engages in the discovery and development of novel immunotherapies and vaccines for the treatment of cancer and infectious disease.

Macrogen

Market Cap: ₩169.3b

Provides precision medicine and bio-engineering healthcare services in Korea and internationally.

Protara Therapeutics

Market Cap: US$121.5m

A clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases.

Spero Therapeutics

Market Cap: US$120.4m

A clinical-stage biopharmaceutical company, focuses on identifying and developing novel treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States.

Pyxis Oncology

Market Cap: US$118.5m

A clinical stage company, engages in the development of therapeutics to treat solid tumors.

IO Biotech

Market Cap: US$117.3m

A clinical-stage biopharmaceutical company, develops immune-modulating therapeutic cancer vaccines based on the T-win technology platform.

Skye Bioscience

Market Cap: US$116.2m

A clinical stage biopharmaceutical company, focuses on developing molecules that modulate G protein-coupled receptors (GPCRs) to treat obesity, overweight, and metabolic diseases.

Biomea Fusion

Market Cap: US$114.3m

A clinical-stage diabetes and obesity medicines company, focuses on the discovery and development of oral covalent small molecule drugs to treat patients with metabolic diseases in the United States.

BioStem Technologies

Market Cap: US$112.3m

A life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services.

Fate Therapeutics

Market Cap: US$112.2m

A clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders in the United States and internationally.

Vistagen Therapeutics

Market Cap: US$111.1m

A clinical-stage biopharmaceutical company, engages in the development and commercialization of therapies for neuropsychiatric and neurological disorders.

Shield Therapeutics

Market Cap: UK£80.7m

A commercial stage specialty pharmaceutical company, focuses on development and commercialization of clinical-stage pharmaceuticals to treat unmet medical needs.

Sensorion

Market Cap: €92.9m

A biotechnology company, develops drug candidates for the treatment of inner ear disorders in France.

Oncolytics Biotech

Market Cap: US$108.4m

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments.

Rapid Micro Biosystems

Market Cap: US$107.9m

A life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally.

Armata Pharmaceuticals

Market Cap: US$107.6m

Operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide.

TScan Therapeutics

Market Cap: US$107.3m

A clinical-stage biotechnology company, develops T cell receptor-engineered T cell (TCR-T) therapies for the treatment of patients with cancer in the United States.